VERIFYME INC (VRME) Fundamental Analysis & Valuation

NASDAQ:VRME • US92346X2062

Current stock price

0.91 USD
+0.01 (+1.11%)
Last:

This VRME fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VRME Profitability Analysis

1.1 Basic Checks

  • VRME had negative earnings in the past year.
  • In the past year VRME had a positive cash flow from operations.
  • VRME had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: VRME reported negative operating cash flow in multiple years.
VRME Yearly Net Income VS EBIT VS OCF VS FCFVRME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

  • VRME's Return On Assets of -35.58% is on the low side compared to the rest of the industry. VRME is outperformed by 79.03% of its industry peers.
  • Looking at the Return On Equity, with a value of -42.50%, VRME is doing worse than 75.81% of the companies in the same industry.
Industry RankSector Rank
ROA -35.58%
ROE -42.5%
ROIC N/A
ROA(3y)-36.52%
ROA(5y)-32.04%
ROE(3y)-56.82%
ROE(5y)-44.86%
ROIC(3y)N/A
ROIC(5y)N/A
VRME Yearly ROA, ROE, ROICVRME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

  • Looking at the Gross Margin, with a value of 34.94%, VRME is in line with its industry, outperforming 54.84% of the companies in the same industry.
  • In the last couple of years the Gross Margin of VRME has declined.
  • The Profit Margin and Operating Margin are not available for VRME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.64%
GM growth 5Y-15.56%
VRME Yearly Profit, Operating, Gross MarginsVRME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. VRME Health Analysis

2.1 Basic Checks

  • VRME does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VRME has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for VRME has been increased compared to 5 years ago.
  • VRME has a worse debt/assets ratio than last year.
VRME Yearly Shares OutstandingVRME Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
VRME Yearly Total Debt VS Total AssetsVRME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • VRME has an Altman-Z score of -4.41. This is a bad value and indicates that VRME is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -4.41, VRME is not doing good in the industry: 84.68% of the companies in the same industry are doing better.
  • VRME has a debt to FCF ratio of 1.96. This is a very positive value and a sign of high solvency as it would only need 1.96 years to pay back of all of its debts.
  • VRME's Debt to FCF ratio of 1.96 is fine compared to the rest of the industry. VRME outperforms 78.23% of its industry peers.
  • A Debt/Equity ratio of 0.07 indicates that VRME is not too dependend on debt financing.
  • VRME's Debt to Equity ratio of 0.07 is in line compared to the rest of the industry. VRME outperforms 53.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.96
Altman-Z -4.41
ROIC/WACCN/A
WACC9.28%
VRME Yearly LT Debt VS Equity VS FCFVRME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

  • VRME has a Current Ratio of 3.70. This indicates that VRME is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.70, VRME is in the better half of the industry, outperforming 70.97% of the companies in the same industry.
  • A Quick Ratio of 3.69 indicates that VRME has no problem at all paying its short term obligations.
  • VRME's Quick ratio of 3.69 is fine compared to the rest of the industry. VRME outperforms 78.23% of its industry peers.
Industry RankSector Rank
Current Ratio 3.7
Quick Ratio 3.69
VRME Yearly Current Assets VS Current LiabilitesVRME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. VRME Growth Analysis

3.1 Past

  • VRME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.58%.
  • Looking at the last year, VRME shows a very negative growth in Revenue. The Revenue has decreased by -14.21% in the last year.
  • The Revenue has been growing by 151.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-22.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.04%
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y203.02%
Revenue growth 5Y151.62%
Sales Q2Q%-7.4%

3.2 Future

  • Based on estimates for the next years, VRME will show a very strong growth in Earnings Per Share. The EPS will grow by 21.68% on average per year.
  • VRME is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -17.34% yearly.
EPS Next Y27.75%
EPS Next 2Y28.29%
EPS Next 3Y21.68%
EPS Next 5YN/A
Revenue Next Year-23.19%
Revenue Next 2Y-15.77%
Revenue Next 3Y-17.34%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VRME Yearly Revenue VS EstimatesVRME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M 25M
VRME Yearly EPS VS EstimatesVRME Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. VRME Valuation Analysis

4.1 Price/Earnings Ratio

  • VRME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year VRME is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VRME Price Earnings VS Forward Price EarningsVRME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • 63.71% of the companies in the same industry are more expensive than VRME, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, VRME is valued a bit cheaper than the industry average as 69.35% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 29.63
EV/EBITDA 19.22
VRME Per share dataVRME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VRME's earnings are expected to grow with 21.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.29%
EPS Next 3Y21.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VRME Dividend Analysis

5.1 Amount

  • No dividends for VRME!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VRME Fundamentals: All Metrics, Ratios and Statistics

VERIFYME INC

NASDAQ:VRME (3/18/2026, 1:44:34 PM)

0.91

+0.01 (+1.11%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-16
Earnings (Next)05-11
Inst Owners9.16%
Inst Owner Change12.97%
Ins Owners19.21%
Ins Owner Change-0.83%
Market Cap11.32M
Revenue(TTM)21.67M
Net Income(TTM)-4.72M
Analysts85
Price Target1.53 (68.13%)
Short Float %4.96%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-196.3%
Min EPS beat(2)-466.45%
Max EPS beat(2)73.86%
EPS beat(4)2
Avg EPS beat(4)-100.67%
Min EPS beat(4)-466.45%
Max EPS beat(4)73.86%
EPS beat(8)5
Avg EPS beat(8)-37.18%
EPS beat(12)8
Avg EPS beat(12)-18.83%
EPS beat(16)10
Avg EPS beat(16)-31.35%
Revenue beat(2)2
Avg Revenue beat(2)6.04%
Min Revenue beat(2)5.07%
Max Revenue beat(2)7.01%
Revenue beat(4)2
Avg Revenue beat(4)-2.67%
Min Revenue beat(4)-14.21%
Max Revenue beat(4)7.01%
Revenue beat(8)3
Avg Revenue beat(8)-2.67%
Revenue beat(12)5
Avg Revenue beat(12)-1.62%
Revenue beat(16)6
Avg Revenue beat(16)-0.72%
PT rev (1m)0%
PT rev (3m)20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-75.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF 29.63
P/OCF 10.13
P/B 1.02
P/tB 1.93
EV/EBITDA 19.22
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)0.03
FCFY3.37%
OCF(TTM)0.09
OCFY9.88%
SpS1.74
BVpS0.89
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -35.58%
ROE -42.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.94%
FCFM 1.76%
ROA(3y)-36.52%
ROA(5y)-32.04%
ROE(3y)-56.82%
ROE(5y)-44.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.64%
GM growth 5Y-15.56%
F-Score4
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.96
Debt/EBITDA 1.99
Cap/Depr 63.45%
Cap/Sales 3.4%
Interest Coverage N/A
Cash Conversion 297.34%
Profit Quality N/A
Current Ratio 3.7
Quick Ratio 3.69
Altman-Z -4.41
F-Score4
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)49.02%
Cap/Depr(5y)92.75%
Cap/Sales(3y)2.21%
Cap/Sales(5y)13.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.04%
EPS Next Y27.75%
EPS Next 2Y28.29%
EPS Next 3Y21.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y203.02%
Revenue growth 5Y151.62%
Sales Q2Q%-7.4%
Revenue Next Year-23.19%
Revenue Next 2Y-15.77%
Revenue Next 3Y-17.34%
Revenue Next 5YN/A
EBIT growth 1Y54.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year121.07%
EBIT Next 3Y30.79%
EBIT Next 5YN/A
FCF growth 1Y130.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y332.92%
OCF growth 3YN/A
OCF growth 5YN/A

VERIFYME INC / VRME Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VERIFYME INC?

ChartMill assigns a fundamental rating of 3 / 10 to VRME.


What is the valuation status of VERIFYME INC (VRME) stock?

ChartMill assigns a valuation rating of 2 / 10 to VERIFYME INC (VRME). This can be considered as Overvalued.


What is the profitability of VRME stock?

VERIFYME INC (VRME) has a profitability rating of 1 / 10.


What is the financial health of VERIFYME INC (VRME) stock?

The financial health rating of VERIFYME INC (VRME) is 5 / 10.